Feasibility of cardiovascular disease risk assessments in rheumatology outpatient clinics: experiences from the nationwide NOCAR project

Abstract

ObjectiveThe European League Against Rheumatism recommends implementing cardiovascular disease (CVD) risk assessments for patients with inflammatory joint diseases (IJDs) into clinical practice. Our goal was to design a structured programme for CVD risk assessments to be implemented into routine rheumatology outpatient clinic visits.MethodsThe NOrwegian Collaboration on Atherosclerosis in patients with Rheumatic joint diseases (NOCAR) started in April 2014 as a quality assurance project including 11 Norwegian rheumatology clinics. CVD risk factors were recorded by adding lipids to routine laboratory tests, self-reporting of CVD risk factors and blood pressure measurements along with the clinical joint examination. The patients’ CVD risks, calculated by the European CVD risk equation SCORE, were evaluated by the rheumatologist. Patients with high or very high CVD risk were referred to their primary care physician for initiation of CVD preventive measures.ResultsData collection (autumn 2015) showed that five of the NOCAR centres had implemented CVD risk assessments. There were 8789 patients eligible for CVD risk evaluation (rheumatoid arthritis (RA), 4483; ankylosing spondylitis (AS), 1663; psoriatic arthritis (PsA), 1928; unspecified and other forms of spondyloarthropathies (SpA), 715) of whom 41.4 % received a CVD risk assessment (RA, 44.7%; AS, 43.4%; PsA, 36.3%; SpA, 30.6%). Considerable differences existed in the proportions of patients receiving CVD risk evaluations across the NOCAR centres.ConclusionPatients with IJD represent a patient group with a high CVD burden that seldom undergoes CVD risk assessments. The NOCAR project lifted the offer of CVD risk evaluation to over 40% in this high-risk patient population.

Association between vitamin D and fatigue in patients with rheumatoid arthritis: a cross-sectional study

“…The proportion of patients who met the 2010 ACR/EULAR classification criteria for RA (89%) was similar to validation studies using diagnosis by a rheumatologist as reference standard 49. Socio-demographic characteristics, disease activity and drug therapy were also very similar to RA patients treated in Norwegian rheumatology clinics at that period 50 51. Furthermore, the variability in fatigue scores and serum 25(OH)D was substantial, ensuring robust correlation analyses.…”

Cardiovascular comorbidity in rheumatic and musculoskeletal diseases: Where we are and how can we move forward?

“…The primary health physician's (who may be overwhelmed by all their other tasks)? How can allied health professionals and services be best integrated in the management of cardiovascular (and other) comorbidities in patients with RMDs in each health system? 23 …”

Cardiovascular disease risk assessment in patients with rheumatoid arthritis: A scoping review

“…Of the 12 studies included, three originated from Norway [ 30 , 31 , 35 ], two from the UK [ 27 , 28 ], two from the Netherlands [ 34 , 36 ] and one from: Ireland [ 26 ], France [ 29 ], Malta [ 33 ], Canada [ 32 ], and the USA [ 25 ]. Studies were published between 2009 [ 26 ] and 2023 [ 34 ].…”